Skip to content
S2124Senate2021-2022 SessionSame asA9633

Expand Hepatitis C Screening

Official title

“Relates to hepatitis C screening testing”

Sponsor Gustavo RiveraSD-33Affects Finance
Status
In Senate Committee
Finance
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Finance

What's happening

This bill expands mandatory hepatitis C screening to individuals born between 1980 and 2000 in addition to previous birth years.

Why it matters

  1. Expanding screening to those born between 1980 and 2000 could help identify undiagnosed hepatitis C cases. in a younger population, catching infections earlier and reducing long-term health complications and costs.

  2. This change reflects shifting patterns in hepatitis C transmission. , as more recent cases are often linked to risk factors such as injection drug use, which have become more prevalent in younger populations.

  3. Mandatory offering of hepatitis C screening in more healthcare settings increases access to early diagnosis and treatment. , potentially reducing the spread of the virus and improving public health outcomes statewide.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Expand Hepatitis C Screening

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Gustavo Rivera

Senator · Senate District 33

Chair, Health

No co-sponsors yet.

History

  1. Reported and committed to finance
  2. Referred to health
  3. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9633Assembly

Expand Hepatitis C Screening

In Assembly Committee · Health · Sponsor Kenneth Zebrowski

Impact 5 · Moderate0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

2124

2021-2022 Regular Sessions

IN SENATE

January 19, 2021

Introduced by Sen. RIVERA -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to hepatitis C screening testing

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 1 of section 2171 of the public health law, as added by chapter 425 of the laws of 2013, is amended to read as follows:

1. Every individual born between the years of nineteen hundred fortyfive and nineteen hundred sixty-five or between the years of nineteen hundred eighty and two thousand who receives health services as an inpatient in a general hospital defined in subdivision ten of section twenty-eight hundred one of this chapter or who receives primary care services in an outpatient department of such hospital or in a diagnostic and treatment center licensed under article twenty-eight of this chapter or from a physician, physician assistant or nurse practitioner providing primary care shall be offered a hepatitis C screening test or hepatitis C diagnostic test unless the health care practitioner providing such services reasonably believes that:

(a) the individual is being treated for a life threatening emergency; or

(b) the individual has previously been offered or has been the subject of a hepatitis C screening test (except that a test shall be offered if otherwise indicated); or

(c) the individual lacks capacity to consent to a hepatitis C screening test.

§ 2. This act shall take effect immediately; provided, however, that the amendments to section 2171 of the public health law made by section one of this act shall not affect the repeal of such section and shall expire and be deemed repealed therewith.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD07018-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to hepatitis C screening testing

Purpose

To expand eligibility for the required offering of hepatitis C screening in hospitals to include individuals born between nineteen hundred and eighty and two thousand.

Summary of provisions

Section one of the bill adds a new § 2171-A to the public health law to include individuals born between the years nineteen hundred and eighty and two thousand who receive health services from a general hospital, outpatient department, licensed diagnostic and treatment center, or directly from a physician, physician's assistant or nurse practitioner to be deemed eligible to receive the required offering of the hepatitis c screening test or hepatitis c diagnostic test.

Section two of the bill establishes the effective date.

Justification

Hepatitis C is a viral infection known to cause liver inflammation, which may lead to liver damage, cirrhosis, liver cancer, liver failure, and death. The virus can cause a short-term (acute) illness character- ized by fever, nausea, abdominal pain, malaise, and jaundice; however, these acute infections often do not cause any symptoms. Nationally, the CDC estimates that 2.4 million Americans are infected with HCV, with half of the carriers unaware of their status. Among those diagnosed with chronic HCV, 60-70% will develop chronic liver disease, 5-20% will develop cirrhosis of the liver, while 1-5% will die due to cirrhosis or liver cancer.

According to the 2017 New York State Department of Health Hepatitis B and C Annual Report, of the 8,280 cases of Hepatitis C reported in New York State (non-inclusive of NYC) in 2017, both the largest number of cases and the highest case rates were observed among persons between the ages of 20-39 (48.6%). The upsurge observed in Hepatitis C diagnosis among young adults are identified as a direct result of the current opioid and intravenous drug use crisis. The two most commonly reported risk factors for chronic Hepatitis C cases in 2017 were participation in injection drug use and non-injection drug use. In 2016, approximately 67% of all emergency department visits and hospital discharges involving opioid use were among individuals between the ages of 18-44, while 58% of opioid-related overdose deaths involved the same age population.

Diagnostic testing is a critical tool utilized to identify the presence of disease within an individual and is proven to increase participation rates among those diagnosed with HCV in active treatment. Therefore, by virtue of the increased prevalence of opioid use and subsequent Hepati- tis C diagnosis among young adults between the ages of 20-40, it is critical to mandate this population be presented with the opportunity

for screening and testing services, while engaged in otherwise routine medical appointments.

Legislative history

2019-2020: S7328/No Same-As

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.